Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Darolutamide for
.
Show all posts
Showing posts with label
Darolutamide for
.
Show all posts
Wednesday, March 27, 2019
Bayer Completes Rolling Submission of NDA for Investigational Drug Darolutamide for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
›
Bayer announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administra...
›
Home
View web version
